Series A - Cyted
Investment Firm
Overview
Cyted uses artificial intelligence (AI) and digital pathology to improve the detection and diagnosis of diseases, including cancer.
Announced Date
May 17, 2023
Closed on Date
Dec 21, 2022
Funding Type
Series A
Highlights
Location
Europe
Social
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
Cyted raised $16724537 on 2023-05-17 in Series A
Cyted uses artificial intelligence (AI) and digital pathology to improve the detection and diagnosis of diseases, including cancer.
Company Funding History
9
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Apr 01, 2023 |  Grant - Cyted | 1 | - | 4.2M |
| Dec 12, 2023 | Grant - Cyted | 1 | - | 1.3M |
| Aug 01, 2021 | Grant - Cyted | 1 | - | 578.7K |
| May 29, 2024 | Non Equity Assistance - Cyted | 1 | - | undefined |
Recent Activity
There is no recent news or activity for this profile.